ClinicalTrials.Veeva

Menu

Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode

S

Shalvata Mental Health Center

Status and phase

Completed
Phase 2

Conditions

Major Depressive Disorder

Treatments

Device: H-coil dTMS

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00807105
0013-07 SHA

Details and patient eligibility

About

This is a prospective open label study of acute and maintenance treatment of MDD. The acute phase consists of daily treatments for 4 weeks. maintenance will be twice a week for eight weeks followed by 10 weeks of once a week treatments.

Enrollment

29 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • MDD patients

Exclusion criteria

  • risk factors for convulsions

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

29 participants in 1 patient group

depressive patients
Experimental group
Description:
patients suffering from deppresion
Treatment:
Device: H-coil dTMS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems